-
foundational entities to fund projects. Collaborate with internal and external research teams, laboratories, and pharmaceutical companies . Draft original research and review articles and publish in peer
-
outcomes through two main research areas: Investigating the biological mechanisms underlying tumor progression: We use single-cell and bulk multiomic techniques to profile tumor samples, focusing
-
and identity assays for release and characterization of these therapeutic products. · You will be expected to perform high quality original research work, participate in the clinical translation
-
the department chair, one of the main goals is to foster translational and correlative studies to bridge basic science and clinical trials.
-
vitro models of the stromal niche, Dr. Danilov’s laboratory models lymphoid disease in vivo. Dr. Danilov’s research is highly translational and involves work with primary samples from patients with
-
. Danilov's laboratory models lymphoid disease in vivo. Dr. Danilov's research is highly translational and involves work with primary samples from patients with lymphoid malignancies. Based on laboratory
-
using transgenic and transplantation mouse models of lymphoproliferative diseases, primary cells from patients, humanized mice, gene editing, classical molecular, cell biology, and biochemistry, and
-
include: working with mice, mammalian cell culture, primary human cell (BM and PBMC) culture and handling, multi-color FLOW cytometry, ELISA, and cell-sorting, co-culture functional assays. · Be
-
cells in human body and the major components of primary tumors and the metastatic sites, macrophages are key effectors mediating tumor immunosurveillance and thus macrophage-based cancer immunotherapy is
-
directed differentiation. Experience in conventional gene editing systems such as CRISPR/Cas9. Preferred qualifications: Experience in analyzing omics data sets. Handling and isolating primary stem cell